Post Traumatic Stress Disorder Clinical Trials in New York, New York

6 studies are recruiting for post traumatic stress disorder in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)

   This study is evaluating the safety and efficacy of TSND-201 in adults with PTSD. Eligible participants will enter a 4-week Treatment Period where they will be randomized 1:1:1 to receive one of two doses of TSND-201 or placebo, once per week. Following the Treatment Period, participants will enter…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Medical Research Network, New York, New York

   Locations

   37 in total

   Run by

   Transcend Therapeutics

   See if you can join NCT07456696 on ClinicalTrials.gov

2. Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers

   This study addresses PTSD symptoms in First Responders and Healthcare workers. Specifically, it tests whether a brief PTSD treatment (talk therapy) effectively treats PTSD when provided to First Responders and Healthcare workers by counselors in Employee Assistance Programs (EAPs). The central hypo…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Cope NewYork-Presbyterian, New York, New York

   Locations

   14 in total

   Run by

   University of Michigan

   See if you can join NCT05751473 on ClinicalTrials.gov

3. General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to Occupational Trauma

   It is expected that large numbers of healthcare workers experience a broad range of psychological reactions and symptoms including anxiety, depression, moral distress, and trauma symptoms that will cause both significant suffering as well as occupational and social impairment. The purpose of this s…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Weill Cornell Medicine, New York, New York

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT04626050 on ClinicalTrials.gov

4. Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI

   This will be a randomized placebo controlled study to test the efficacy of cannabidiol (CBD) as a treatment for symptoms of post-traumatic stress disorder (PTSD). Subjects, 120 in total, will be males and females with PTSD, half of which will have comorbid mild traumatic brain injury (TBI). There w…

   Stage

   Phase 2

   Ages

   18 to 70

   Site

   New York University School of Medicine, New York, New York

   Run by

   NYU Langone Health

   See if you can join NCT04550377 on ClinicalTrials.gov

5. Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD

   This is a double-blind, 2-group randomized controlled trial evaluating the effects of topiramate versus placebo in patients with comorbid PTSD and moderate-to-severe AUD. This trial will provide one of the first rigorous tests of whether the effects of topiramate in AUD generalize to patients with …

   Stage

   Phase 2

   Ages

   18 to 70

   Site

   New York University School of Medicine, New York, New York

   Run by

   NYU Langone Health

   See if you can join NCT03667846 on ClinicalTrials.gov

6. NYSCF Scientific Discovery Biobank

   The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and store th…

   Stage

   Not phased

   Ages

   0 and older

   Site

   New York Stem Cell Foundation Research Institute, New York, New York

   Run by

   New York Stem Cell Foundation Research Institute

   See if you can join NCT06203106 on ClinicalTrials.gov